Cite
Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma
MLA
Ye Q, et al. “Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma.” Drug Design, Development and Therapy, vol. ume 15, Apr. 2021, pp. 1765–77. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.3c32d81c8aa144d790d9b780eaa71c2b&authtype=sso&custid=ns315887.
APA
Ye Q, Zhang Q, Yao H, Xu A, Liu Y, Qi J, Zhang H, & Zhang J. (2021). Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma. Drug Design, Development and Therapy, ume 15, 1765–1777.
Chicago
Ye Q, Zhang Q, Yao H, Xu A, Liu Y, Qi J, Zhang H, and Zhang J. 2021. “Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma.” Drug Design, Development and Therapy ume 15 (April): 1765–77. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.3c32d81c8aa144d790d9b780eaa71c2b&authtype=sso&custid=ns315887.